The oxidative stress paradigm in arbovirus infections: mechanisms and therapeutic insights.

Redox Rep · 2026 · PMC13084857 · PMID 41986933

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

While a drug's redox-lowering effect might be significant in a Phase I trial at one site, it can be invisible in a Phase II trial at another site.

also in 2,457 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.